BioSynth
BioSynth

BioSynth

Measured by AhrefsDR63Ahrefs DR: 63/100. Above median. Measured by Ahrefs. Median 44.Measured by StartupHub.aiAgent36Agent Readiness: 36/100. Below median. Measured by StartupHub.ai. Median 41.Measured by Google PageSpeedSpeed46Site Speed: 46/100. Bottom 25%. Measured by Google PageSpeed. Median 62.Measured by StartupHub.aiTrust65Data Trust: 65/100. Above median. Measured by StartupHub.ai. Median 61.

Synthetic biology platform for sustainable material production.

2023ActiveCambridge, United Kingdom

About

BioSynth is a synthetic biology company focused on developing a platform for the sustainable production of materials. They leverage biological processes to create novel materials with reduced environmental impact, aiming to disrupt traditional manufacturing methods.

Key facts

Website
biosynth.com
Headquarters
Cambridge, United Kingdom
Founded
2023
Total funding
$10M (Seed)
Business model
B2B

Funding rounds

Funding rounds raised by BioSynth
DateRoundAmountLead investors
1 May 2023Seed$10M

Tech stack

Detected on biosynth.com, last scanned 20 Oct 2026.

CDN
Cloudflare
Email provider
Microsoft 365
Email marketing
SAP Emarsys

BioSynth scores 63. Does yours?

That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.

Add first review

Frequently asked

Is BioSynth trustworthy and reputable?

StartupHub's Data Trust & Reputation score for BioSynth is 65 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has BioSynth raised?

BioSynth has raised a total of $10M in funding. The most recent round on record is Seed.

Public record

SEC filings, insider activity, nonprofit links and pay benchmarks for BioSynth